血清Cys C在DM2早期肾损害中的临床价值

下载PDF

导出

摘要近几年研究报道,血清胱抑素C（Cys C）能反映肾小球滤过膜通透性的早期变化[1].本文就2型糖尿病（DM2）患者血清Cys C浓度变化与尿微量白蛋白排泄率（UAER）的关系进行探讨,以评价其在DM2患者早期肾损害中的价值.

作者李施泉陈彤吴俊渊胡建忠

机构地区南通大学第二附属医院检验科

出处《放射免疫学杂志》 CAS 2012年第1期114-115,共2页 Journal of Radioimmanology

关键词早期肾损害临床价值 CYS DM2 血清尿微量白蛋白排泄率 2型糖尿病肾小球滤过

参考文献6

1Recd CH.Diagnostic applications of Cystatin C[J].Br J Biomed Sci,2000,57(4):323-329.
2Mogensen CE.Prediction of clinical diabetic nephropathy in IDDM pations alternative to microalburia[J].Diabetes,1990,39:761-764.
3Tarif N,Alwakeel JS,Mitwalli AH,et al.Serum Cystatin C as a marker of renal function in patients with acute renal failure[J].Saudi J Kidney Dis Transpl,2008,19(6):918-923.
4Jibom T,Abrahamson M,Wallin H,et al.Cystatin C is highly expressed in the human male reproductive system[J].J Androl,2004,25 (4):564-572.
5Helin I,Axenram M,Grubb A.Serum Cystatin C as a determinant of glomerular filtration rate in children[J].Clin Nephrol,1998,49(4):221-225.
6Laura P,Stefano T,Daniela L,et al.Cystatin C and estimates of renal function:Searching for a better measure of kidney function in diabetic patient[J].Clin Chem,2007,53 (3):480-488.

放射免疫学杂志

2012年第1期

内容加载中请稍等...